Speaker Detail

Christopher Viehbacher is CEO of Sanofi as well as a member of its board and Strategy Committee. He is also chairman of Genzyme. After beginning his career at PricewaterhouseCoopers, he acquired broad international experience in Europe, the U.S. and Canada with GlaxoSmithKline. In his last position, Viehbacher was president of pharmaceutical operations in North America, a member of the board and co-chairman of the Portfolio Management Board. He is the former chairman of PhRMA in the United States (December 2010-April 2012) and is the current chairman of the CEO Roundtable on Cancer, which brings together U.S. employers to develop workplace initiatives that reduce the risk of cancer, enable early diagnosis and hasten the discovery of novel and more effective diagnostic tools and anti-cancer therapies. More than 120 organizations are now members, covering nearly 3 million employees. Viehbacher, who lived in France for nine years, was made a knight of the French Legion of Honor in 2003. A certified public accountant, he is a graduate of Queen's University in Ontario.